Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

PharmaCyte Biotech, Inc. - Common Stock (NQ:PMCB)

0.9016 -0.0403 (-4.28%)
Streaming Delayed Price Updated: 10:02 AM EST, Dec 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about PharmaCyte Biotech, Inc. - Common Stock

< Previous 1 2 3 4 Next >
News headline image
Why Are PharmaCyte Shares Moving Higher On Thursday? ↗
PharmaCyte Biotech Inc (NASDAQ: PMCB) stock is moving higher in reaction to the first test results of the biocompatibility studies of its CypCaps trial product candidate. These... 
Via Benzinga
News headline image
PharmaCyte Biotech Announces Positive Results of Biocompatibility Study for FDA
From PharmaCyte Biotech, Inc.
Via Business Wire
News headline image
41 Stocks Moving In Friday's Mid-Day Session ↗
Gainers IVERIC bio, Inc. (NASDAQ: ISEE) shares climbed 64.4% to $14.29 after Apellis Pharmaceuticals reported results from its Phase 3 DERBY and OAKS studies in geographic... 
Via Benzinga
News headline image
60 Biggest Movers From Friday ↗
Gainers IVERIC bio, Inc. (NASDAQ: ISEE) shares surged 62.5% to close at $14.12 on Friday after Apellis Pharmaceuticals reported results from its Phase 3 DERBY and OAKS studies in... 
Via Benzinga
News headline image
Why Is PharmaCyte Biotech Stock Moving Higher In Premarket Thursday? ↗
The stock price of PharmaCyte Biotech Inc (NASDAQ: PMCB) is trading higher during premarket today. Investors are expecting a major announcement from the company... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Gainers Soligenix (NASDAQ:SNGX) stock increased by 22.85% to $1.29 during Thursday's pre-market session. The company's market cap stands at $51.7 million. Cardiff... 
Via Benzinga
News headline image
PharmaCyte Biotech to Participate in H.C. Wainwright 23rd Annual Global Investment Conference
From PharmaCyte Biotech, Inc.
Via Business Wire
News headline image
PharmaCyte Biotech Establishes 18-Month Shelf Life for Clinical Trial Product in Ongoing Stability Study
From PharmaCyte Biotech, Inc.
Via Business Wire
News headline image
PharmaCyte Biotech Expands Product Pipeline to Include Diabetes and Malignant Ascites Following $90-Million Capital Raise
From PharmaCyte Biotech, Inc.
Via Business Wire
News headline image
60 Biggest Movers From Yesterday ↗
Gainers Trillium Therapeutics Inc. (NASDAQ: TRIL) shares jumped 188.8% to close at $17.59 on Monday after the company agreed to be acquired by Pfizer for $18.50 per share,... 
Via Benzinga
News headline image
PharmaCyte Biotech Announces Closing of $70 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
From PharmaCyte Biotech, Inc.
Via Business Wire
News headline image
35 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Trillium Therapeutics Inc. (NASDAQ: TRIL) shares climbed 187.8% to $17.53 after the company agreed to be acquired by Pfizer for $18.50 per share, implying an equity value... 
Via Benzinga
News headline image
25 Stocks Moving in Monday's Pre-Market Session ↗
Gainers Greenpro Capital Corp. (NASDAQ: GRNQ) rose 48.7% to $1.13 in pre-market trading. Greenpro Capital shares gained 16% on Friday after the company announced its Angkasa-X... 
Via Benzinga
News headline image
22 Stocks Moving in Friday's Pre-Market Session ↗
Gainers GeoVax Labs, Inc.. (NASDAQ: GOVX) shares rose 72.1% to $7.40 in pre-market trading after the company announced it presented COVID-19 vaccine data at the European Society... 
Via Benzinga
News headline image
58 Biggest Movers From Yesterday ↗
Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares climbed 63.7% to close at $1.22 on Thursday after dropping 12% on Wednesday. Sonnet BioTherapeutics recently... 
Via Benzinga
News headline image
Mid-Afternoon Market Update: Dow Falls 170 Points; DLocal Shares Spike Higher ↗
Toward the end of trading Thursday, the Dow traded down 0.49% to 34,790.15 while the NASDAQ fell 0.07% to 14,515.39. The S&P also fell, dropping 0.14% to 4,394.20. The U.... 
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Gainers Sonnet BioTherapeutics (NASDAQ:SONN) shares moved upwards by 110.49% to $1.57 during Thursday's regular session. Trading volume for Sonnet BioTherapeutics'... 
Via Benzinga
News headline image
Mid-Day Market Update: Macy's Jumps After Q2 Results; PharmaCyte Biotech Shares Drop ↗
Midway through trading Thursday, the Dow traded down 0.40% to 34,819.43 while the NASDAQ rose 0.07% to 14,535.52. The S&P also fell, dropping 0.03% to 4,398.74. The U.S. has... 
Via Benzinga
Topics Stocks
News headline image
38 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares jumped 141% to $1.7950 after dropping 12% on Wednesday. Sonnet BioTherapeutics recently reported its financial... 
Via Benzinga
News headline image
Mid-Morning Market Update: Markets Mostly Flat; Estée Lauder Sales Top Views ↗
Following the market opening Thursday, the Dow traded down 0.06% to 34,940.82 while the NASDAQ rose 0.05% to 14,532.58. The S&P also rose, gaining 0.03% to 4,401.45. The U.S.... 
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Gainers Sonnet BioTherapeutics (NASDAQ:SONN) shares increased by 97.28% to $1.47 during Thursday's pre-market session. The market value of their outstanding shares is... 
Via Benzinga
News headline image
PharmaCyte Biotech Announces $70 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
From PharmaCyte Biotech, Inc.
Via Business Wire
News headline image
21 Stocks Moving in Thursday's Pre-Market Session ↗
Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares rose 86.5% to $1.39 in pre-market trading after dropping 12% on Wednesday. Sonnet BioTherapeutics recently... 
Via Benzinga
News headline image
46 Biggest Movers From Yesterday ↗
Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares climbed 189.5% to close at $9.90 on Wednesday after surging over 15% on Tuesday. SGOCO Group, Ltd. (NASDAQ: SGOC) surged 67... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Gainers Protagenic Therapeutics (NASDAQ:PTIX... 
Via Benzinga
News headline image
What's Up With PharmaCyte Biotech Shares Today? ↗
PharmaCyte Biotech Inc (NASDAQ: PMCB) is surging higher Wednesday on abnormally-high volume following the company's recent listing on the Nasdaq. PharmaCyte Biotech ... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
Gainers PharmaCyte Biotech (NASDAQ:PMCB) shares rose 119.0% to $7.49 during Wednesday's regular session. Trading volume for PharmaCyte Biotech's stock is 144.3... 
Via Benzinga
News headline image
34 Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares jumped 139% to $8.18 after surging over 15% on Tuesday. Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares surged 58% to $... 
Via Benzinga
News headline image
Mid-Morning Market Update: Markets Mixed; Target Reports Upbeat Profit ↗
Following the market opening Wednesday, the Dow traded down 0.12% to 35,300.85 while the NASDAQ rose 0.03% to 14,660.26. The S&P also fell, dropping 0.04% to 4,446.09. The U.S... 
Via Benzinga
Topics Stocks
News headline image
PMCB Stock: 14 Things to Know About PharmaCyte Biotech as Shares Skyrocket ↗
PharmaCyte Biotech (PMCB) stock is taking off Wednesday and there are a few things that potential investors need to know about the company. 
Via InvestorPlace
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.